自拍无码精品一区二区|亚洲А∨天堂久久精品|国产日韩欧美一区二区视|亚洲av高清dvd丝袜|中文一级无码黄片精品视频|亚洲无码网站在线免费观看|免费无码又爽又刺激又污又黄|成人免费无码婬片在线观看免费

159-2642-3062 027-65317797
服務(wù)熱線(工作日:9:00-17:30)

瀏覽量: 165

  • 產(chǎn)品名稱: Research Grade Idarucizumab ( 艾達(dá)賽珠單抗 )
  • 產(chǎn)品貨號(hào): CSD00317
  • 貨期: 現(xiàn)貨
  • 價(jià)格與訂購(gòu): 2480
  • 數(shù)量:
    庫(kù)存: 100
  • 規(guī)格: 100μg
  • 產(chǎn)品信息
  • 如何訂購(gòu)
    貨號(hào)(Catalog No.)
    CSD00317
    通用名INN
    Idarucizumab
    純度(Purity)
    >95%
    濃度( Concentration)
    1mg/ml
    Formulation
    PBS buffer PH7.5
    Source
    CHO cells
    內(nèi)毒素(Endotoxin level)
    Please contact with the lab for this information.
    產(chǎn)品描述(Description)
    Idarucizumab is a humanized monoclonal antibody fragment (Fab) derived from an immunoglobulin G1 isotype molecule that binds to and inactivates the oral anticoagulant dabigatran, thereby reversing its anticoagulant effect. As a direct acting oral anticoagulant (DOAC), one of the risks associated with the use of dabigatran includes bleeding, espeically when given to patients at increased risk (elderly, chronic kidney disease, concomitant NSAID or warfarin use, etc).Approved under the tradename Praxbind (FDA), idarucizumab is indicated for the emergency treatment of dabigatran-associated bleeding in life-threatening or surgically induced situations. Its use is associated with immediate, complete and sustained reversal of the anticoagulant effects of dabigatran.Idarucizumab protein structure can be viewed below, with disulfide bridges at the following points: H22-H95, H149-H205, H225-L-219, L23-L93, L139-L199.
    別名(Alternative names)
    aDabi-Fab,anti-dabigatran,antidote for dabigatran
    靶點(diǎn);物種(Specificity target name;species)
    MS4A1[Homo sapiens]
    活性研究(體外/體內(nèi)研究)(Activity in vitro)
    Dabigatran selectively and reversibly inhibited human thrombin(Ki: 4.5 nM) as well as thrombin-induced platelet aggregation (IC50: 10 nM), while showing no inhibitory effect on other platelet-stimulating agents. Thrombin generation in platelet-poor plasma (PPP), measured as the endogenous thrombin potential (ETP) was inhibited concentration-dependently (IC50: 0.56 μM). Dabigatran demonstrated concentration-dependent anticoagulant effects in various species in vitro, doubling the activated partial thromboplastin time (aPTT), prothrombin time (PT) and ecarin clotting time (ECT) in human PPP at concentrations of 0.23, 0.83 and 0.18 μM, respectively.
    種類(Species)
    Humanized
    受體鑒定(Receptor identification)
    Fab
    CAS
    1362509-93-0
    存儲(chǔ)條件(Storage)
    Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
    Store at +4°C short term (1-2 weeks).
    Store at -20 °C 12 months.
    Store at -80°C long term.
    Note
    For research use only .
黄龙县| 大同县| 棋牌| 清涧县| 成武县| 额敏县| 昌黎县| 永城市| 广东省| 襄垣县| 邓州市| 徐水县| 正阳县| 凤阳县| 朔州市| 岳普湖县| 九寨沟县| 淮南市| 恩平市| 湖口县| 溧水县| 略阳县| 襄汾县| 五常市| 宁阳县| 西乡县| 四会市| 郴州市| 龙井市| 田林县| 安阳市| 合山市| 湘阴县| 石台县| 上犹县| 永和县| 武城县| 吴川市| 侯马市| 东平县| 德清县|